a2 Milk Company Ltd (ASX:A2M) reports another quarter of soaring revenue

a2 Milk Company Ltd (ASX:A2M) has reported another quarter of big revenue growth.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

a2 Milk Company Ltd (ASX: A2M) has given a trading update for the nine months to 31 March 2018. The company also gave its outlook for the full-year FY18 result.

Trading update

The company said that for the nine months to 31 March 2018 the total revenue was NZ$660 million, which is around a 70% increase on the prior corresponding period.

a2 attributed this performance to sales growth in both the nutritional products and liquid milk categories. The company reminded investors that this includes the impact of key seasonal sales from key China selling events weighted towards the first half of the financial year.

FY18 Outlook

In regards to the full-year result for FY18, the company said that it anticipates total revenue will be between NZ$900 million to NZ$920 million. a2 said that this includes the planned transition to new infant formula packaging during the fourth quarter. The range of revenue would be growth of around 64% to 67% in FY18 – which is a bigger increase than the increase in FY17.

The company's gross margin is expected to be roughly the same as the first half of FY18, given the benefit of 'throughput efficiencies' and currency movements.

It also warned that the total marketing investment is now going to be in the range of NZ$82 million to NZ$87 million, due to the expansion in the US and China – this is around double FY17's spend.

Foolish takeaway

This is a solid update and it seems growth is nowhere done yet. The US and China expansions could add a lot more revenue over time considering how big the populations are in those regions.

I can understand why the share price has been a rocket over the past year. It's currently trading at around 46x FY18's estimated earnings, but growth could continue strongly over the coming years to make this valuation seem more acceptable.

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of A2 Milk. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »